Enzo Biochem (NYSE:ENZ) Research Coverage Started at StockNews.com

StockNews.com began coverage on shares of Enzo Biochem (NYSE:ENZ) in a research note released on Friday. The firm issued a hold rating on the medical research company’s stock.

Enzo Biochem Stock Performance

Shares of Enzo Biochem stock opened at $0.46 on Friday. The stock’s 50 day simple moving average is $0.60 and its 200-day simple moving average is $0.90. Enzo Biochem has a 1-year low of $0.41 and a 1-year high of $1.32.

Enzo Biochem (NYSE:ENZ) last issued its earnings results on Monday, December 16th. The medical research company reported ($0.05) earnings per share for the quarter. Enzo Biochem had a negative return on equity of 7.96% and a negative net margin of 75.34%.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the business. BBR Partners LLC acquired a new position in Enzo Biochem during the third quarter worth $112,000. Lepercq Multi Asset Fund purchased a new position in Enzo Biochem in the fourth quarter valued at $88,000. Mink Brook Asset Management LLC purchased a new position in Enzo Biochem in the fourth quarter valued at $577,000. Wittenberg Investment Management Inc. increased its holdings in Enzo Biochem by 60.1% in the fourth quarter. Wittenberg Investment Management Inc. now owns 187,537 shares of the medical research company’s stock valued at $134,000 after buying an additional 70,400 shares during the last quarter. Finally, Virtu Financial LLC purchased a new position in Enzo Biochem in the fourth quarter valued at $35,000. 36.90% of the stock is currently owned by institutional investors and hedge funds.

Enzo Biochem Company Profile

Enzo Biochem, Inc develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis.